Emerging therapeutic targets in oncology: urokinase-type plasminogen activator system

By Magill C.   Katz B.A.   Mackman R.L.  

Expert Opinion on Therapeutic Targets, Vol. 3, Iss. 1, 1999-03 ,pp. : 109-133

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of the Protease Domain of Urokinase-Type Plasminogen Activator

By  

Current Pharmaceutical Design, Vol. 8, Iss. 28, 2002-12 ,pp. : 2541-2558

Bentham Science Publishers

Access to resources Recommend Favorite

Small molecule inhibitors of urokinase-type plasminogen activator

By Rockway Todd W  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 6, 2003-06 ,pp. : 773-786

Informa Healthcare

Access to resources Recommend Favorite

Preface The Urokinase-type Plasminogen Activator System in Cancer and other Pathological Conditions: Introduction and Perspective [Hot Topic: The Urokinase-type Plasminogen Activator System in Cancer (Executive Editor : S. Rosenberg)].

By  

Current Pharmaceutical Design, Vol. 9, Iss. 19, 2003-07 ,pp. : iv-iv

Bentham Science Publishers

Access to resources Recommend Favorite

The Urokinase-type Plasminogen Activator and the Generation of Inhibitors of Urokinase Activity and Signaling

By  

Current Pharmaceutical Design, Vol. 17, Iss. 19, 2011-06 ,pp. : 1944-1961

Bentham Science Publishers

Access to resources Recommend Favorite